Peginterferon alpha-2b: a new approach to improving response in hepatitis C patients

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.8, 2001-08, pp. : 1307-1315

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peginterferon α-2b in the treatment of hepatitis C

By Weitzman Gil Jacobson Ira

Future Virology, Vol. 1, Iss. 3, 2006-05 ,pp. : 279-292

Future Medicine

Access to resources Recommend Favorite

Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response: A Decision Analysis Based on German Guidelines

By Siebert Uwe Sroczynski Gaby Aidelsburger Pamela

PharmacoEconomics, Vol. 27, Iss. 4, 2009-06 ,pp. : 341-354

Adis International

Access to resources Recommend Favorite

Population pharmacokinetics of peginterferon alfa-2b in pediatric patients with chronic hepatitis C

By Xu C. Gupta S. Krishna G. Cutler D. Wirth S. Galoppo C. Ciocca M. Kolz K. Noviello S. Sniukiene V.

European Journal of Clinical Pharmacology, Vol. 69, Iss. 12, 2013-12 ,pp. : 2045-2054

Springer Publishing Company

Access to resources Recommend Favorite

Virological Response in Patients with Hepatitis C Virus Genotype 1b and a High Viral Load: Impact of Peginterferon-α-2a plus Ribavirin Dose Reductions and Host-Related Factors

By Yamada Gotaro

Clinical Drug Investigation, Vol. 28, Iss. 1, 2008-01 ,pp. : 9-16

Adis International

Access to resources Recommend Favorite

Financial Impact of Two Different Ways of Evaluating Early Virological Response to Peginterferon- -2b Plus Ribavirin Therapy in Treatment-Naive Patients with Chronic Hepatitis C Virus Genotype 1

By Buti Maria

PharmacoEconomics, Vol. 23, Iss. 10, 2005-01 ,pp. : 1043-1055

Adis International

Access to resources Recommend Favorite